Doctor profile · Federal record

Dr. Ramin Mirhashemi, M.D.

Gynecologic Oncology Physician (CMS: Gynecological Oncology) · Torrance, CA

  • NPI 1992744874
  • Accepts Medicare
  • 33 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
23600 Telo Ave, Suite 250
Torrance, CA 905054035
(310) 375-8446
fax (310) 375-8489
Mailing address
351 Hospital RD, Suite 507
Newport Beach, CA 926633509

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
April 1, 2016
Year of graduation
1993 — 33 yrs since
Specialty taxonomy
207VX0201X — NUCC code
State license (1)
California #G86713
Medicaid
CA #00G867130

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1992744874. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
41,452
Distinct HCPCS
10
Medicare allowed
$487,079
HCPCS Description Services Patients Avg allowed
J9267 Injection, paclitaxel, 1 mg 23,367 19 $0
Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg 6,243 11 $31
J1100 Injection, dexamethasone sodium phosphate, 1 mg 5,330 27 $0
J2469 Injection, palonosetron hcl, 25 mcg 2,650 25 $1
J1626 Injection, granisetron hydrochloride, 100 mcg 980 13 $0
J9045 Injection, carboplatin, 50 mg 596 19 $3
96375 Injection of additional new drug or substance into vein 396 28 $18
96413 Administration of chemotherapy into vein, 1 hour or less 358 28 $152
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 356 28 $33
99214 Established patient office or other outpatient visit, 30-39 minutes 292 197 $139

In context: peer comparison

Among 1 peers in Torrance Gynecologic Oncology Physician, average services per provider: 1,480. This provider delivers 28× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,456
Transactions
45
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Medtronic, INC. 4 $284.84
GlaxoSmithKline, LLC. 13 $211.86
AstraZeneca Pharmaceuticals Lp 5 $201.34
Intuitive Surgical, INC. 1 $129.56
Myriad Genetic Laboratories, INC. 2 $123.39
Abbvie INC. 4 $100.19
Pfizer INC. 4 $94.90
Merck Sharp & Dohme LLC 2 $52.70
Boston Scientific Corporation 2 $48.70
Amneal Pharmaceuticals LLC 2 $45.67
Ethicon US, LLC 2 $36.60
Baxter Healthcare 1 $29.06
Urgo Medical North America, LLC 1 $26.56
Teleflex LLC 1 $21.28
Conmed Corporation 1 $18.58

By nature of payment

Food and Beverage
$1,456

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
449
Patients
284
Total drug cost
$338,804
Drug Type Claims Patients Total cost
Amoxicillin-Clavulanate Potass (Amoxicillin/Potassium Clav) Brand 113 100 $567
Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) Brand 93 88 $399
Prochlorperazine Maleate Generic 52 34 $572
Doxycycline Hyclate Generic 22 21 $160
Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) Brand 22 19 $60
Dexamethasone Generic 20 11 $299
Gabapentin Generic 20 0 $128
Myrbetriq (Mirabegron) Brand 17 0 $10,518
Famotidine Generic 16 0 $34
Estradiol Generic 15 0 $2,094

Frequently asked questions

Auto-generated from federal data
What is Dr. Ramin Mirhashemi's medical specialty?
Dr. Ramin Mirhashemi practices Gynecologic Oncology Physician in Torrance, CA.
Where does Dr. Ramin Mirhashemi practice?
Dr. Ramin Mirhashemi practices at 23600 Telo Ave, Torrance, CA 905054035. Office phone: 3103758446.
What is Dr. Ramin Mirhashemi's NPI?
Dr. Ramin Mirhashemi's National Provider Identifier (NPI) is 1992744874, issued by NPPES.
Does Dr. Ramin Mirhashemi accept Medicare assignment?
Yes. Dr. Ramin Mirhashemi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ramin Mirhashemi commonly perform?
Top Medicare-reported procedures in 2023: Injection, paclitaxel, 1 mg (HCPCS J9267); Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS Q5118); Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100). Source: CMS Medicare Physician & Other Practitioners file.